MCI Onehealth Announces Investment in and Commercial Support for Acorn Biolabs, Inc.

Ontario Industry Updates
Written By Viktoriya Shabat
MCI-onehealth.jpg

MCI Onehealth Technologies Inc., a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, has announced an investment of $250,000 with Acorn Biolabs, Inc. (“Acorn Biolabs,” “Acorn”), a Toronto-based biotechnology company. Acorn Biolabs is revolutionizing regenerative and precision medicine

Viktoriya Shabat
Previous

Canada’s Biotech Industry Will Need to be Stronger if We Want to be Ready for the Next Pandemic
Next

Canada-Israel Cardiovascular Innovation Forum Announced Selected Applications